162 related articles for article (PubMed ID: 33413879)
1. Chronic Active Antibody-Mediated Rejection Following COVID-19 Infection in a Kidney Transplant Recipient: A Case Report.
Abuzeineh M; Tariq A; Rosenberg A; Brennan DC
Transplant Proc; 2021 May; 53(4):1202-1206. PubMed ID: 33413879
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
Front Immunol; 2020; 11():342. PubMed ID: 32184785
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
4. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
[TBL] [Abstract][Full Text] [Related]
5. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
[TBL] [Abstract][Full Text] [Related]
6. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.
Solomon S; Colovai A; Del Rio M; Hayde N
Pediatr Nephrol; 2020 Feb; 35(2):261-270. PubMed ID: 31732803
[TBL] [Abstract][Full Text] [Related]
8. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
9. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
10. Double-Filtration Plasmapheresis Plus Low-Dose Anti-thymocyte Globulin and Tacrolimus in Asian Living-Donor Kidney Transplantation With Donor-Specific Anti-HLA Antibody.
Kantachuvesiri S; Ingsathit A; Thammanichanond D; Choochaeam K; Sra-Ium S; Kitiyakara C; Nongnuch A; Sakulchairungrueng B; Worawichawong S
Transplant Proc; 2021 Apr; 53(3):995-1000. PubMed ID: 32948312
[TBL] [Abstract][Full Text] [Related]
11. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
[TBL] [Abstract][Full Text] [Related]
12. Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Nourié N; Nassereddine H; Mouawad S; Chebbou L; Ghaleb R; Abbas F; Azar H
BMC Nephrol; 2022 Mar; 23(1):91. PubMed ID: 35247969
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
Mayer KA; Doberer K; Tillgren A; Viard T; Haindl S; Krivanec S; Reindl-Schwaighofer R; Eder M; Eskandary F; Casas S; Wahrmann M; Regele H; Böhmig GA
Transpl Int; 2021 Sep; 34(9):1689-1702. PubMed ID: 34448270
[TBL] [Abstract][Full Text] [Related]
14. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
[TBL] [Abstract][Full Text] [Related]
15. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
Kataria A; Kumar D; Gupta G
Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
17. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With
Zhu L; Guo Z; Sa R; Guo H; Li J; Chen G
Front Immunol; 2021; 12():661614. PubMed ID: 33936098
[TBL] [Abstract][Full Text] [Related]
19. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.
Huang E; Sethi S; Peng A; Najjar R; Mirocha J; Haas M; Vo A; Jordan SC
Am J Transplant; 2019 Jun; 19(6):1663-1670. PubMed ID: 30725531
[TBL] [Abstract][Full Text] [Related]
20. Association Between Total Cell Free DNA and SARS-CoV-2 In Kidney Transplant Patients: A Preliminary Study.
Reusing JO; Yoo J; Desai A; Brossart K; McCormick S; Malashevich AK; Bloom MS; Fehringer G; White R; Billings PR; Tabriziani H; Demko ZP; Gauthier P; Akkina SK; David-Neto E
Transplant Proc; 2022; 54(6):1446-1454. PubMed ID: 35618524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
